U.S. Capital Markets Stock News

Fourth quarter earnings and capital returns in focus OneSpaWorld Holdings (OSW) reported its fourth quarter and full year 2025 results, with higher revenue and slightly lower net income, alongside fresh revenue guidance, a quarterly dividend, increased impairments and a completed share buyback tranche. See our latest analysis for OneSpaWorld Holdings. The earnings release, dividend affirmation and completed share buyback came after a choppy period for the share price, with a 1 month share...

In February 2026, Interparfums, Inc. reported record 2025 sales of US$1.49 billion and higher earnings per share, while its board kept the annual dividend at US$3.20 per share and reaffirmed 2026 guidance of US$1.48 billion in sales and EPS of US$4.85. Beyond the headline growth, the year was shaped by successful new fragrance launches, fresh long-term licenses, and broader global distribution that helped support performance despite tariff and currency pressures. We’ll now explore how this...

BETA Technologies (BETA) has drawn fresh attention after a recent pullback, with the stock showing negative returns over the past month and past 3 months while the business continues to report rapid annual revenue growth. See our latest analysis for BETA Technologies. The latest pullback has extended BETA Technologies' year to date share price return to a 31.21% decline, with the 90 day share price return of 31.06% pointing to fading momentum despite a flat 7 day move and recent revenue...

In late February 2026, United Therapeutics announced TreSMI, a new generation of inhaled treprostinil intended to reduce coughing, while Liquidia continued to await a court decision on the critical ’327 patent litigation that could shape its competitive footing in pulmonary hypertension. The combination of a potential rival inhaled treprostinil product and unresolved patent risk introduces fresh uncertainty around how Liquidia’s PRINT-enabled franchise might compete and grow within a...

In February 2026, Sanofi and Teva Pharmaceutical Industries reported that duvakitug, an investigational TL1A-targeting antibody, achieved durable 44-week clinical and endoscopic efficacy with consistent safety in ulcerative colitis and Crohn’s disease responders in the RELIEVE UCCD long-term extension study. A separate recent milestone saw the US FDA accept Teva’s New Drug Application for TEV-749, a once-monthly olanzapine injection for adult schizophrenia, underscoring the company’s push...

First Financial Bankshares recently filed its 2025 10-K, detailing its financial results, risk management profile, and an extension of its stock repurchase authorization allowing the company to buy back up to 5,000,000 common shares through July 31, 2026. The filing also underscores a continued focus on organic expansion in non-metropolitan Texas markets and potential acquisitions of high-quality banks, supported by strong regulatory capital ratios and a consistent dividend policy. Next,...

Event context and recent share performance National Vision Holdings (EYE) has drawn investor attention recently as its share price moved to a last close of $26.97, with returns of about 2.4% over the past month and a 3.6% decline over the past 3 months. See our latest analysis for National Vision Holdings. Looking beyond the past month, the 1 year total shareholder return of 112.2% contrasts with a modest 3.93% year to date share price return. This suggests momentum has cooled after a strong...

In late February 2026, Clarivate Plc reported fourth-quarter 2025 sales of US$617 million, full-year 2025 sales of US$2.46 billion, and a quarterly net income of US$3.1 million compared with a net loss a year earlier, alongside sharply lower goodwill and intangible asset impairments of US$15.0 million. The company also issued 2026 guidance pointing to ongoing net losses of US$124 million to US$189 million on revenues of US$2.30 billion to US$2.42 billion, highlighting that profitability...

FedEx has filed a lawsuit against the US government seeking reimbursement of tariffs that were ruled invalid by the Supreme Court. The company has pledged to return any recovered tariff funds to affected shippers and consumers. The move has triggered class-action lawsuits from customers and drawn political scrutiny over how potential multibillion dollar tariff refunds will be handled. For investors watching NYSE:FDX, this legal push comes at a time when the stock trades around $387.0 and...

Why the latest earnings matter for National Storage Affiliates Trust National Storage Affiliates Trust (NSA) just released fourth quarter 2025 results that exceeded earnings and revenue expectations, supported by better occupancy trends, revenue growth across its portfolio, and active buying and selling of properties. Management paired the numbers with fresh 2026 guidance, pointing to same store revenue growth and a focus on cost discipline. The company also highlighted further brand...

Omnicom Group (NYSE:OMC) is acquiring Interpublic and combining the two global advertising groups into a single company. The company plans to accelerate divestitures of noncore and underperforming businesses as part of the integration. Management is targeting substantial cost synergies, including significant workforce reductions across the combined group. Omnicom has authorized a $5b share repurchase program alongside the integration and restructuring efforts. Omnicom Group, listed on the...

Recent moves in StepStone Group (STEP) have been closely tied to macro data, with stronger-than-expected inflation readings and shifting Federal Reserve rate expectations pressuring financial and private-market-focused stocks. See our latest analysis for StepStone Group. The US$43.14 share price reflects a sharp reset, with a 30 day share price return of 39.0% and a year to date share price return of 35.2%. However, the 3 year total shareholder return of 60.3% and 5 year total shareholder...

Kroger (NYSE:KR) appoints former Walmart executive Greg Foran as its new CEO, following a leadership change linked to operational challenges. The company faced a failed US$25b acquisition and rising grocery competition, prompting a board driven shift at the top. Kroger also expands its healthcare footprint by promoting access to GLP-1 medications and integrated wellness support across pharmacy and grocery. Kroger, a major US grocery and retail operator, is entering a new chapter with Greg...

SM Energy Company recently reported fourth-quarter 2025 results showing revenue of US$705 million and net income of US$109 million, alongside record full-year production and operating cash flow. At the same time, the company raised its annual dividend by 10% to US$0.88 per share, outlined a US$500 million buyback program, and agreed to sell South Texas assets for US$950 million to further strengthen its balance sheet. We’ll now examine how the increased dividend and capital return framework...

Regency Centers completed a public offering of $450 million in senior unsecured notes due 2033. The issuance is intended to support balance sheet optimization and ongoing development activities. The company trades on the NasdaqGS under the ticker NasdaqGS:REG, with a current share price of $79.0. For investors watching NasdaqGS:REG, this $450 million notes offering is a fresh data point on how Regency Centers is managing its capital structure. The stock is at $79.0, with returns of 2.8%...

If you are wondering whether NVR at around US$7,517.79 is giving you fair value or asking too much, you are not alone. This article is built to answer that question head on. Over shorter periods the stock has been relatively muted, with a 0.8% decline over the last 7 days and a 1.5% decline over the last 30 days, while the return over the last year sits at 3.8% and the 3 year and 5 year returns are 43.3% and 62.6% respectively. Recent coverage around NVR has focused on its position in the US...

LPL Financial Holdings (LPLA) has drawn attention after a period of weaker share performance, with returns over the past month, past 3 months, and year all in negative territory, even though multi year total returns remain positive. See our latest analysis for LPL Financial Holdings. The recent 1 month share price return of a 17.59% decline and year to date share price return of a 16.94% decline point to fading near term momentum, even though the 5 year total shareholder return of 129.88%...

Owens Corning (NYSE:OC) reported a net loss for the fourth quarter, reversing net income from the same period a year earlier. The company also posted a full year net loss, a material deterioration compared with the prior year's profitability. Recent results came in below earnings expectations, highlighting weaker than anticipated financial performance. For investors watching NYSE:OC, this shift to losses comes with the stock recently closing at $122.07. Shares are down 8.0% over the past...

If you are wondering whether Boise Cascade's share price still reflects its real worth, looking at how the market has treated the stock over different time frames is a useful starting point. The stock last closed at US$82.74, with returns of 0.7% over 7 days, 3.0% over 30 days, 11.6% year to date, but a 19.3% decline over 1 year and longer term returns of 36.4% over 3 years and 107.2% over 5 years. Recent headlines around Boise Cascade have focused on its position as a major supplier of...

Kilroy Realty (KRC) has been drawing attention after a sustained share price slide, with the stock down about 14% over the past month and 30% over the past 3 months. See our latest analysis for Kilroy Realty. That recent slide comes on top of a wider loss of momentum, with a 1 day share price return of 6.87% decline and a year to date share price return of 21.57% decline. The 1 year total shareholder return of 11.39% decline suggests income has softened the blow only slightly. If this...

FDA lifts clinical hold on Intellia Therapeutics' MAGNITUDE-2 ATTR amyloidosis trial, allowing global enrollment to resume with updated safety protocols. Intellia completes phase 3 enrollment ahead of schedule in the HAELO trial for lonvo-z, a one time gene editing therapy for hereditary angioedema. These steps advance Intellia Therapeutics' late stage pipeline and move its gene editing candidates closer to potential approval and commercialization. For investors watching Intellia...

If you are wondering whether Century Aluminum at around US$51.56 is still reasonably priced or already rich, you are not alone. This article is written to help you think that through clearly. The stock has been volatile recently, with a 2.1% decline over the last 7 days, a 5.4% gain over 30 days, a 25.9% return year to date, and a 172.1% return over the past year. The 3 year and 5 year returns are both very large. Recent news coverage has focused on Century Aluminum in the context of the...

If you are trying to work out whether Lineage at around US$40.52 is a bargain or just fairly priced, you are in the right place. The stock has recently posted returns of 5.8% over 7 days, 12.6% over 30 days and 14.4% year to date, although the 1 year return sits at a 29.3% decline. Recent attention on Lineage has focused on its position in the US real estate space and how investors are reassessing companies in the sector, which helps frame these recent price moves. Coverage has regularly...

Global Net Lease, Inc. recently reported fourth-quarter 2025 results showing quarterly sales of US$116.95 million and net income of US$48.18 million, while also completing a US$1.80 billion sale of its multi-tenant retail portfolio and materially reducing its debt. This portfolio transformation into a pure-play single-tenant net lease REIT, coupled with investment-grade credit upgrades from Fitch and S&P Global, marks a significant shift in Global Net Lease’s balance sheet strength and...